- Coordinator
- Vib Vzw, Belgium
- Runs
- 1 September 2023 to 31 August 2025
- Status
- Running
- EU funding
- €176k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101062043
What the project is doing
In the project's own words, from its summary on CORDIS.
Many bacteria possess a paracrystaline protein coat named the S-layer. S-layers cover the entire cell surface and are involved in protection, virulence, cell-shape maintenance and communication. Lattice integrity is essential for S-layer function, meaning that its assembly must be intimately coordinated with cell growth and division. Some studies have reported that S-layer biogenesis co-localizes with peptidoglycan (PG) synthesis, however, the underlying molecular mechanisms remain unknown.
Here, I will investigate the molecular regulatory network that orchestrates S-layer assembly, cell division and PG synthesis in the human pathogen Bacillus anthracis, where S-layer defects render the bacterium avirulent, making this ultrastructure an attractive therapeutic target. In the SLYDIV project I will 1) structurally and functionally compare Sap and EA1, the exponential and stationary phase S-layer proteins of B. anthracis 2) follow their in vivo assembly using time-resolved labelling and fluorescent microscopy and 3) uncovering the molecular interactions that couple S-layer assembly with the PG and/or cell division machinery.
I will make use of chemicals that selectively target the cell cycle or cell division and monitor localization of S-layer assembly, will use nanobodies that disturb S-layer integrity and monitor the localization of cell wall synthesis, and use my interactomics experience to discover contact partners of S-layer and PG synthesis. Thus, SLYDIV is a multidisciplinary and integrative project that combines structural biology, biophysics, cell imaging, and microbiology.
In addition, SLYDIV meets my solid knowledge on bacterial cell division with the host labs’ expertise on S-layer structure and function. The SLYDIV project aims to lead to a major breakthrough in the basic understanding of the regulation of the bacterial cell envelope, while it will pave the way for specific novel molecular therapies against B. Anthracis, a Category A bioterrorist agent.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Vib Vzw | Zwijnaarde - Gent | Belgium | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI